Nintedanib | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nintedanib
U.S. EXCLUSIVITIES

PharmaCompass Sponsored Ads

Contact Supplier

Midas Nintedanib Esylate

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Nintedanib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers, 20 USDMF, 5 EU WC, 3 KDMF, 13 NDC API, 30 Listed Suppliers, $ API Reference Price

44 API Suppliers
20 USDMF
5 EU WC
3 KDMF
13 NDC API
30 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

18 Intermediates Suppliers

18 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 8 FDA Orange Book, 15 Europe, 2 Canada, 4 Australia, 2 South Africa, 4 Listed Dossiers

35 FDF Dossiers
8 FDA Orange Book
15 Europe
2 Canada
4 Australia
2 South Africa
4 Listed Dossiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 69 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
69 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Finished Drug Prices, 4 Annual Reports

1 US Medicaid Prescriptions
9 Finished Drug Prices
4 Annual Reports

MARKET PLACE

4 APIs, 6 FDF Dossiers

4 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 4 US Exclusivities

18 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 7,969 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 4BOEHRINGER INGELHEIM

filter Product Reset all filters

4 All

01 4NINTEDANIB ESYLATE

filter Exclusivity Expiration Date Reset all filters

4 All

01 22026-09-06

02 22027-03-06

filter Exclusivity Code Reset all filters

4 All

01 2ODE-261

02 2PED

Fermion Nintedanib Esylate

Product Main Page

BOEHRINGER INGELHEIM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NINTEDANIB ESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2027-03-06

Application Number

205832

Product Number

2

Exclusivity Details

01

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

American Pharma Summit

Not Confirmed

BOEHRINGER INGELHEIM

Germany

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NINTEDANIB ESYLATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2027-03-06

Application Number : 205832

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BOEHRINGER INGELHEIM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NINTEDANIB ESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2027-03-06

Application Number

205832

Product Number

1

Exclusivity Details

02

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

American Pharma Summit

Not Confirmed

BOEHRINGER INGELHEIM

Germany

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NINTEDANIB ESYLATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2027-03-06

Application Number : 205832

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BOEHRINGER INGELHEIM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NINTEDANIB ESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-261

Exclusivity Expiration Date

2026-09-06

Application Number

205832

Product Number

1

Exclusivity Details

03

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

American Pharma Summit

Not Confirmed

BOEHRINGER INGELHEIM

Germany

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NINTEDANIB ESYLATE

Exclusivity Code : ODE-261

Exclusivity Expiration Date : 2026-09-06

Application Number : 205832

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

BOEHRINGER INGELHEIM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NINTEDANIB ESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-261

Exclusivity Expiration Date

2026-09-06

Application Number

205832

Product Number

2

Exclusivity Details

04

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

American Pharma Summit

Not Confirmed

BOEHRINGER INGELHEIM

Germany

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NINTEDANIB ESYLATE

Exclusivity Code : ODE-261

Exclusivity Expiration Date : 2026-09-06

Application Number : 205832

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?